CONMED Corp. Stock
Price
Target price
€64.00
€64.00
-3.030%
-2.0
-3.030%
€106.18
09.05.24 / Frankfurt
WKN: 886793 / Symbol: CNMD / Name: CONMED / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
CONMED Corp. Stock
CONMED Corp. took a tumble today and lost -€2.000 (-3.030%).
We see a rather positive sentiment for CONMED Corp. with 12 Buy predictions and 1 Sell predictions.
As a result the target price of 106 € shows a very positive potential of 65.63% compared to the current price of 64.0 € for CONMED Corp..
Pros and Cons of CONMED Corp. in the next few years
Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CONMED Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CONMED Corp. | -3.030% | 4.762% | -7.692% | -40.541% | -34.653% | -44.068% | -7.654% |
| Neogen Corp. | -3.510% | 0.885% | -12.308% | -25.974% | -37.705% | -70.955% | -57.692% |
| Bio-Rad Labs Inc. A | 3.230% | -2.536% | -18.894% | -24.223% | -13.590% | -49.260% | - |
| Merit Medical Systems | -1.360% | 4.255% | 10.526% | -4.545% | 8.088% | 38.679% | 47.650% |
Comments
CONMED Co. (NYSE: CNMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $107.00 price target on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $115.00 to $75.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $100.00 to $95.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
News
Med-tech stock Conmed dips ahead of big Q4 report...opportunity?
When Utica, NY-based medical technology company CONMED Corporation (NYSE:CNMD) reports fourth quarter financials after the close on Wednesday, it is expected to post some of its best growth in
